Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-15-005025
Filing Date
2015-08-13
Accepted
2015-08-12 17:52:24
Documents
9
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ctxr_10q.htm 10-Q 271689
2 CERTIFICATION ctxr_ex311.htm EX-31.1 9693
3 CERTIFICATION ctxr_ex321.htm EX-32.1 3811
  Complete submission text file 0001477932-15-005025.txt   1619060

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT ctxr-20150630.xml EX-101.INS 211593
5 XBRL TAXONOMY EXTENSION SCHEMA ctxr-20150630.xsd EX-101.SCH 25789
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctxr-20150630_cal.xml EX-101.CAL 31094
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctxr-20150630_def.xml EX-101.DEF 60000
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctxr-20150630_lab.xml EX-101.LAB 144929
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctxr-20150630_pre.xml EX-101.PRE 119884
Mailing Address 63 GREAT ROAD MAYNARD MA 01754
Business Address 63 GREAT ROAD MAYNARD MA 01754 (978) 938-0338
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 333-170781 | Film No.: 151048142
SIC: 3714 Motor Vehicle Parts & Accessories